首页> 外文OA文献 >The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

【2h】

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

机译：Alzheimer疾病中血管紧张素转化酶抑制剂与血管紧张素受体阻滞剂和认知下降的使用：血脑屏障渗透和Apoeε4载体状态的重要性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Michael Ouk; Che-Yuan Wu; Jennifer S. Rabin; Aaron Jackson; Jodi D. Edwards; Joel Ramirez; Mario Masellis; Richard H. Swartz; Nathan Herrmann; Krista L. Lanctôt; Sandra E. Black; Walter Swardfager;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status [J] . Michael Ouk, Che-Yuan Wu, Jennifer S. Rabin, Alzheimer s Research & Therapy . 2021 ,第1期

机译：血管紧张素转化酶抑制剂与血管紧张素受体阻滞剂的使用和阿尔茨海默病的认知下降：血脑屏障渗透和Apoeε4载体状态的重要性
2. COST-EFFECTIVENSS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VS. ANGIOTENSIN II RECEPTOR BLOCKERS AS FIRST-LINE TREATMENT IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE [J] . Clark L. A., Whitmire S. M., Patton S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017 ,第5期

机译：血管紧张素转换酶抑制剂的成本效果与血管紧张素II受体阻滞剂作为常染色体显性多囊肾疾病中的一线治疗
3. COST-EFFECTIVENSS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VS. ANGIOTENSIN II RECEPTOR BLOCKERS AS FIRST-LINE TREATMENT IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE [J] . Clark L. A., Whitmire S. M., Patton S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017 ,第5期

机译：血管紧张素转换酶抑制剂的成本效果与血管紧张素II受体阻滞剂作为常染色体显性多囊肾疾病中的一线治疗
4. Using neuroblastoma as an Alzheimer's disease model to study the effect of angiotensin converting enzyme inhibitors [C] . Yu-Chang Tyan, Ming-Hui Yang American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：使用神经母细胞瘤作为阿尔茨海默病模型研究血管紧张素转化酶抑制剂的作用
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and [O] . Michael Ouk, Che-Yuan Wu, Jennifer S. Rabin, 2021

机译：使用血管紧张素转化酶抑制剂与阿尔茨海默病的血管紧张素受体阻滞剂和认知下降：血脑屏障渗透的重要性
7. Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population [O] . K Rygiel 2016

机译：血管紧张素转换酶抑制剂能否影响阿尔茨海默病早期的认知能力下降？老年患者人群研究证据概述

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

著录项

相似文献

相关主题

期刊订阅